Indian pharma will continue to stare at single digit growth: ICRA
The aggregate revenues of ICRA ’s sample comprising 21 companies grew marginally at 0.8% in Q2FY2018 Vs the prior year as against Q1 FY2018 growth at -8.8%. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 3, 2018 Category: Pharmaceuticals Source Type: news

Hetero launches HumiraTM biosimilar in India
The product will be marketed by Hetero Healthcare under the brand name ‘MaburaTM’ in India, the company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 3, 2018 Category: Pharmaceuticals Source Type: news

NPPA fixes retail prices of 14 formulations
Drug price regulator has also asked manufacturers to furnish quarterly return regarding production, import and sale of their products. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 2, 2018 Category: Pharmaceuticals Source Type: news

PMBJPs selling drugs up to 96% cheaper than branded equivalents
Mandaviya, in a written reply in the Lok Sabha , said that the branded generic medicines are generally sold at higher prices in comparison to their unbranded generic equivalents. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 2, 2018 Category: Pharmaceuticals Source Type: news

Apax Partners, Carlyle front-runners for Mankind Pharma stake sale
Apax Partners& Carlyle have been shortlisted and are currently the front-runners for the proposed stake sale by Mankind Pharma, said two sources. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 1, 2018 Category: Pharmaceuticals Source Type: news

Vivimed Labs gets additional $7.5 million funding from OrbiMed Asia
The company had earlier received USD 42.5 million from OrbiMed Asia in September 2017, Vivimed Labs said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 1, 2018 Category: Pharmaceuticals Source Type: news

Mylan-Biocon's breast cancer biosimilar gets ANVISA nod
Biosimilar trastuzumab, indicated for breast cancer treatment, has been co-developed by Biocon and Mylan. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 29, 2017 Category: Pharmaceuticals Source Type: news

Zydus Pharmaceuticals gets USFDA nod for OCD treatment drug
The company has received final approval from the US Food and Drug Administration (USFDA) to market the drug in the strength of 25 mg, 50 mg and 75 mg, Zydus Cadila said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 29, 2017 Category: Pharmaceuticals Source Type: news

Lupin gets USFDA nod for generic psoriasis treatment solution
The USFDA approval to Lupin's calcipotriene topical solution is for strength of 0.005 per cent (scalp solution), the company said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 28, 2017 Category: Pharmaceuticals Source Type: news

Pharma cos' revenues seen clipping at 9% over next 3 yrs
Over half of the exports are to the regulated markets in the West but those are set to de-grow by 5 per cent this fiscal, after growing 3 per cent last fiscal. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 28, 2017 Category: Pharmaceuticals Source Type: news

Lupin moves court fearing tax on pre-GST stock
​Lupin, like many other pharma companies, is worried that some of the stock lying in its godowns could face double taxation due to goods and services tax (GST) regulations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 27, 2017 Category: Pharmaceuticals Source Type: news

Expired, damaged drugs returned are not “supplies”; to save Rs 500 crore hit
Indian Pharmaceutical Alliance had noted that the industry annually receives around Rs 3300 to Rs 5500 crore in expired or damaged stock and expected a hit of about Rs 500 crore. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 27, 2017 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets USFDA nod for Fondaparinux Sodium injection
The approved ANDA is a bioequivalent and therapeutically equivalent to the reference listed drug product Arixtra Injection of Mylan Ireland, said Aurobindo Pharma. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 27, 2017 Category: Pharmaceuticals Source Type: news

USFDA accepts Sun Pharma arm's ophthalmic drug application
Sun Pharma said that post the USFDA approval, OTX-101 will be commercialised in the US by Sun Ophthalmics, the branded ophthalmics division of Sun Pharma. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 27, 2017 Category: Pharmaceuticals Source Type: news

Government's medicare drive pinches pharma, private hospitals in 2017
Summing up 2017, Indian Pharmaceutical Alliance (IPA) Secretary General D G Shah said that the industry was never up against so many challenges in one single year before. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 27, 2017 Category: Pharmaceuticals Source Type: news

Dr.Reddy's launches anti-cancer injection in US market
The drug, which is used to treat certain types of cancer, was earlier approved by the US Food and Drug Administration (USFDA), DRL said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 26, 2017 Category: Pharmaceuticals Source Type: news

Rhizen receives USFDA orphan drug designation for cancer drug
The USFDA has granted orphan drug designation for Tenalisib (RP6530)... for the treatment of patients with peripheral T-cell lymphoma (PTCL), Alembic Pharmaceuticals said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 26, 2017 Category: Pharmaceuticals Source Type: news

Fooya! founder in patent war over digital vaccine with US Pharma giant
Moderna has filed for the 'digital vaccines' trademark and the US Patent and Trademark Office (USPTO) is opening up the case for public comment tomorrow. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 25, 2017 Category: Pharmaceuticals Source Type: news

Sun Pharma recalls two batches of diabetic drug from US market
The drug was manufactured for Ranbaxy Laboratories Inc Jacksonville in USA by a contract manufacturer and distributed by Sun Pharma's subsidiary in Cranbury. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 21, 2017 Category: Pharmaceuticals Source Type: news

Rein in MRP or government will, syringe makers told
The NPPA had issued notice to the hospital following allegations of over-charging by the parents of the girl who died after leaving the hospital following dengue treatment for over two weeks. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 21, 2017 Category: Pharmaceuticals Source Type: news

Max group claims 'stay' on licence cancellation order
A week ago, the hospital group had filed an appeal in the the Court of the Financial Commissioner against the cancellation of the licence of its hospital in north-west Delhi. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 20, 2017 Category: Pharmaceuticals Source Type: news

India developing bulk drugs to reduce import dependence
The country's import of active pharmaceutical ingredients (APIs) from China is high but there is enough capacity for domestic production, says DGCI (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 20, 2017 Category: Pharmaceuticals Source Type: news

Strides bags majority stake in South Africa's Trinity
Strides Pharma Asia Pte, which is a wholly-owned subsidiary of Strides Shasun, to acquire 55% stake for a cash consideration of Rs 27.5 cr. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 20, 2017 Category: Pharmaceuticals Source Type: news

Morepen Labs gets USFDA nod for asthma drug
Morepen is the market leader for Montelukast in India with over 50 per cent market share, supplying to almost all major finished dosage manufacturers in India (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 20, 2017 Category: Pharmaceuticals Source Type: news

Zydus Wellness CFO Amit B Jain resigns
Firm's flagship brand 'Sugar Free' has 94 per cent market share in the sugar substitute category. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 20, 2017 Category: Pharmaceuticals Source Type: news

China accounts for 66 per cent of India's bulk drug imports in FY'17
India's import of active pharmaceutical ingredients (API) from China stood at Rs 12,254.97 crore in 2016-17, while that from the US was at Rs 820.18 crore. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 19, 2017 Category: Pharmaceuticals Source Type: news

Dr Reddys settles 6-year-old litigation with US justice department over packaging case
The case pertains to a litigation filed by the US Consumer Commission that had alleged that the packaging of five blister packaged prescription had caused harm to children. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 19, 2017 Category: Pharmaceuticals Source Type: news

Over dependence on drug imports from China harmful for India: IPCA
According to IPCA, over 75 per cent of India's bulk drug imports come from China which has emerged as a cause of concern for the industry. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 19, 2017 Category: Pharmaceuticals Source Type: news

Lincoln Pharma gets patent for anti-malarial drug
The company expects significant rise in the revenue from exports to Africa after the introduction of this injection in the African market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 19, 2017 Category: Pharmaceuticals Source Type: news

Biocon to invest in Uttar Pradesh health sector
During a road show organized by UP government in Bengaluru on Monday as a precursor to the investors' summit in February 2018, Majumdar-Shaw met UP's industrial development minister Satish Mahana. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 19, 2017 Category: Pharmaceuticals Source Type: news

Dr Reddy's arm settles case with US govt for USD 5 mn
The drugmaker and the US Department of Justice agreed to the settlement of the action without any adjudication of any issue of fact or law. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 19, 2017 Category: Pharmaceuticals Source Type: news

Drug companies fear double tax on old stocks
Under the current law, pharmaceutical companies that have stock lying with them that is older than 12 months are not entitled to a set off against GST liability. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 18, 2017 Category: Pharmaceuticals Source Type: news

NPPA notifies prices of 65 essential formulations
"NPPA has fixed/revised ceiling prices/Retail Prices of 65 scheduled formulations under Drugs (Prices Control) Order, 2013," the regulator said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 18, 2017 Category: Pharmaceuticals Source Type: news

Drug makers can now expect more regular checkups from USFDA
Indian Pharmaceutical Alliance secretary general DG Shah agreed that inspections could be stepped up but termed it a long-term benefit. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 17, 2017 Category: Pharmaceuticals Source Type: news

Aurobindo, Dr Reddy's Laboratories frontrunners to buy out bankrupt Orchid Pharma
Orchid was on the Reserve Bank of India's second list of 28 defaulters that had to be referred to the NCLT before December 31 if no resolution was found by December 13. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 17, 2017 Category: Pharmaceuticals Source Type: news

SC for relook into 349 FDC medicines by drug advisory board
The FDC were banned by the Centre on the grounds that they involved "risk" to humans and safer alternatives were available. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 16, 2017 Category: Pharmaceuticals Source Type: news

SC refers 349 FDC medicines to Drug Advisory Board for relook
A bench said that the 349 FDCs were banned pursuant to the Kokate Committee report, by notifications of the central government under Section 26A of the Drugs Act. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 15, 2017 Category: Pharmaceuticals Source Type: news

Govt fixes ceiling prices of 849 formulations till Nov
Ceiling prices of 59 formulations were reduced by more than ​ 40 per cent with respect to maximum price: Govt (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 15, 2017 Category: Pharmaceuticals Source Type: news

Supreme Court asks drugs advisory body to decide fate of over 334 banned combination medicines
​​Companies can make and sell the 349 contested fixed dose combination drugs (FDCs) while Drugs Technical Advisory Board (DTAB) deliberates on the issue. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 14, 2017 Category: Pharmaceuticals Source Type: news

SC asks drugs advisory body to decide fate of 349 banned combination medicines
​​Companies can make and sell the 349 contested fixed dose combination drugs (FDCs) while Drugs Technical Advisory Board (DTAB) deliberates on the issue. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 14, 2017 Category: Pharmaceuticals Source Type: news

Cadila gets USFDA nod for generic drug to treat Parkinson's
The Ahmedabad-based firm also received final approval from the USFDA to market Nitrofurantoin Capsules USP, used for treating acute uncomplicated urinary tract infections, in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 14, 2017 Category: Pharmaceuticals Source Type: news

Lupin gets USFDA nod for generic contraceptive tablets
The company has received final approval from the US Food and Drug Administration (USFDA) to market Tydemy, which is a generic version of Bayer HealthCare Pharmaceuticals' Safyral Tablets, Lupin said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 14, 2017 Category: Pharmaceuticals Source Type: news

Torrent Pharma completes acquisition of Unichem Laboratories Ltd
he acquisition will accelerate Torrent's presence in the chronic space especially in the high growth segments of Indian Pharma market like Cardiology, Diabetology and Gastroenterology. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 14, 2017 Category: Pharmaceuticals Source Type: news

PerkinElmer may invest over $100 million in India by 2022
Over the next 3-5 years, the company is mulling investment of over $100 million in India for these purposes, according to him. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 13, 2017 Category: Pharmaceuticals Source Type: news

CCI starts probe on alleged price fixing of key anti diabetic drugs
Emcure also did not respond to an email query as of press time while USV remained unreachable for a comment. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 13, 2017 Category: Pharmaceuticals Source Type: news

JB Chemicals & Pharma gets USFDA nod for hypertension tablets
"The USFDA has approved the company's supplementary Abbreviated New Drug Application (ANDA) for Atenolol tablets USP 25mg, 50mg and 100 mg," J B Chemicals& Pharmaceuticals said in a BSE filing today. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 13, 2017 Category: Pharmaceuticals Source Type: news

Alembic Pharmaceuticals gets USFDA go-ahead for bladder drug
According to IMS December 2016 data, Darifenacin extended release tablets had an estimated market size of USD 64 million. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 12, 2017 Category: Pharmaceuticals Source Type: news

Novo Nordisk India and Torrent Pharma expand their insulin manufacturing facility
Torrent Pharmaceuticals and Novo Nordisk began their partnership 25 years ago in 1992 with the manufacture and launch of insulin in 40 IU vials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 11, 2017 Category: Pharmaceuticals Source Type: news

Granules' arm completes audit with USFDA
Granules Pharmaceuticals Inc, a wholly-owned foreign subsidiary of the company completed its first audit from December 4-8, 2017 by the USFDA with one observation," the company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 11, 2017 Category: Pharmaceuticals Source Type: news

Suven gets product patents from India, US
Suven Life said the granted claims of the patents are being developed as therapeutic agents and useful in treatment of cognitive impairment associated with neurodegenerative disorders. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 11, 2017 Category: Pharmaceuticals Source Type: news